generic glp 1 agonists America's Poison Centers GLP-1 Receptor Agonists May Lower
Description
Paton, J
A thorough medical evaluation is mandatory before any prescription
Clinical trials report gastrointestinal adverse events in 40-50% of tirzepatide users, with nausea alone affecting roughly one in three participants
Specific subtypes assessed included Alzheimers disease, vascular dementia, frontotemporal dementia, Parkinsons disease, extrapyramidal and movement disorders, and dementia with Lewy bodies
Ozempic/semaglutide is recommended for patients with specific clinical indications, budget considerations, or thin-fat phenotype without high insulin resistance
